©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 109671
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.109671
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.109671
Table 2 Type of nephrotic syndrome across the age groups of the cohort, n (%)
| Current age group, years | Type of NS | Total | |||
| SSNS | SRNS | SDNS | FRNS | ||
| 1–3 | 2 (40) | 1 (20) | 1 (20) | 1 (20) | 5 (100) |
| 3–6 | 19 (59) | 4 (12.5) | 7 (21.8) | 2 (6.3) | 32 (100) |
| 6–12 | 29 (44.6) | 11 (16.9) | 20 (30.7) | 5 (7.7) | 65 (100) |
| 12–15 | 3 (23) | 6 (46.1) | 3 (23.1) | 1 (7.7) | 13 (100) |
| > 15 | 0 | 1 (14.2) | 4 (57.1) | 2 (28.6) | 7 (100) |
| 53 (43.4) | 23 (18.9) | 35 (28.7) | 11 (9) | n = 122 | |
- Citation: Ajarmeh SA, Akl K, Al Shawabkeh M, Al Baramki J. Steroid response and outcomes in childhood nephrotic syndrome: A multicenter, cross-sectional study from Jordan. World J Clin Pediatr 2025; 14(4): 109671
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/109671.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.109671